Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Acute Myeloid Leukemia(AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01371981
What this trial is testing

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaLeukemia CutisMyeloid Neoplasm+1 more
National Cancer Institute (NCI) 1,645
Not applicableLooking for participantsNCT06472128
What this trial is testing

Novel Digital Application for Patients With Acute Leukemia

Who this might be right for
Relapsed Adult Acute Myeloid LeukemiaPrimary Refractory Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia
Massachusetts General Hospital 200
Not applicableLooking for participantsNCT06845592
What this trial is testing

Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia

Who this might be right for
Acute Myeloid Leukaemia (AML)Acute Lymphoblastic Leukemia ALLHigh Risk Leukaemia+1 more
University Of Perugia 51
Early research (Phase 1)Not Yet RecruitingNCT07780565
What this trial is testing

Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Looking for participantsNCT06717958
What this trial is testing

Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation

Who this might be right for
AMLMDS
Technische Universität Dresden 76
Testing effectiveness (Phase 2)UnknownNCT05066958
What this trial is testing

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Testing effectiveness (Phase 2)Ended earlyNCT01532635
What this trial is testing

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Who this might be right for
Hematologic MalignancyLeukemiaAcute Lymphoblastic Leukemia+9 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4
Not applicableActive Not RecruitingNCT03178617
What this trial is testing

High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaLymphoblastic Lymphoma+1 more
City of Hope Medical Center 214
Testing effectiveness (Phase 2)Study completedNCT01019317
What this trial is testing

Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
LeukemiaAMLMDS+1 more
M.D. Anderson Cancer Center 151
Testing effectiveness (Phase 2)Ended earlyNCT00818649
What this trial is testing

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 16
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT03067571
What this trial is testing

Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
High Risk Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07575412
What this trial is testing

SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more
The First Affiliated Hospital of Soochow University 180
Testing effectiveness (Phase 2)Study completedNCT00303667
What this trial is testing

Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT01686334
What this trial is testing

Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia
Zwi Berneman 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07643636
What this trial is testing

Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML

Who this might be right for
AML (Acute Myeloid Leukemia)
Dongguan People's Hospital 46
Testing effectiveness (Phase 2)Study completedNCT02215070
What this trial is testing

Pasireotide in Prevention of GI Toxicity

Who this might be right for
Hematological Malignancies
Anthony Sung, MD 37
Not applicableStudy completedNCT02121418
What this trial is testing

Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm

Who this might be right for
Chronic Myelomonocytic Leukemia-2Myelodysplastic SyndromeMyeloproliferative Neoplasm+1 more
University of Washington 12
Large-scale testing (Phase 3)Study completedNCT00412360
What this trial is testing

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+2 more
Medical College of Wisconsin 224
Testing effectiveness (Phase 2)WithdrawnNCT03059615
What this trial is testing

A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndromes
Immune System Key Ltd
Next Page